SIRT1 shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc. | Biocompare.com

Supplier Images
Published Figures

SIRT1 shRNA Plasmid (h)

Be the first to write a review!

Citations:

Figures:

Supplier Page from
Santa Cruz Biotechnology, Inc. for
SIRT1 shRNA Plasmid (h)

Product Specs
ItemSIRT1 shRNA Plasmid (h)
CompanySanta Cruz Biotechnology, Inc.
Price $592.00Supplier Page View Company Product Page
Catalog Numbersc-40986-SH
Quantity20 µg
TypeshRNA Plasmid
Specieshuman
NCBI Full Gene Namesirtuin 1
NCBI Gene AliasesSIR2, SIR2L1, SIR2alpha
RNA TypeshRNA Clones
Vector Type (Standardized)Lentiviral

Add to Compare List

Santa Cruz Biotechnology, Inc.

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) NAD Supplement Alleviates Intestinal Barrier Injury Induced by Ethanol Via Protecting Epithelial Mitochondrial FunctionNutrientsDecember 30, 2022Li W, Zhou Y, Pang N, Hu Q, Li Q, Sun Y, Ding Y, Gu Y, Xiao Y, Gao M, et al.

(2) Hyperacetylation of the C-terminal domain of p53 inhibits the formation of the p53/p21 complexBiochemical and biophysical research communicationsDecember 20, 2022Kim U, Kim KS, Park JK, Um HD.

(3) "Hyperglycemic Neurovasculature-On-A-Chip to Study the Effect of SIRT1-Targeted Therapy for the Type 3 Diabetes ""Alzheimer's Disease"""Advanced science (Weinheim, Baden-Wurttemberg, Germany)December 1, 2022Jang M, Choi N, Kim HN.brain microvascular channel. Construction of SIRT1‐Depleted and ‐Overexpressing Cells SIRT1 shRNA (sc‐40986‐sh, Santa Cruz, United States) was used to generate SIRT1‐depleted hBMECs following the manufacturer's

(4) Elaiophylin Inhibits Tumorigenesis of Human Lung Adenocarcinoma by Inhibiting Mitophagy via Suppression of SIRT1/Nrf2 SignalingCancersNovember 25, 2022Ji J, Wang K, Meng X, Zhong H, Li X, Zhao H, Xie G, Xie Y, Wang X, Zhu X.

(5) SARS-CoV-2 virus NSP14 Impairs NRF2/HMOX1 activation by targeting Sirtuin 1Cellular & molecular immunologyAugust 1, 2022Zhang S, Wang J, Wang L, Aliyari S, Cheng G.

(6) Dual Effects of Korean Red Ginseng on Astrocytes and Neural Stem Cells in Traumatic Brain Injury: The HO-1-Tom20 Axis as a Putative Target for Mitochondrial FunctionCellsMarch 4, 2022Kim M, Moon S, Jeon HS, Kim S, Koh SH, Chang MS, Kim YM, Choi YK.

(7) Protocatechualdehyde Rescues Oxygen-Glucose Deprivation/Reoxygenation-Induced Endothelial Cells Injury by Inducing Autophagy and Inhibiting Apoptosis via Regulation of SIRT1Frontiers in pharmacologyJanuary 1, 2022Cao S, Chen S, Qiao X, Guo Y, Liu F, Ding Z, Jin B.

(8) SIRT4-Catalyzed Deacetylation of Axin1 Modulates the Wnt/β-Catenin Signaling PathwayFrontiers in oncologyJanuary 1, 2022Wang Y, Yue J, Xiao M, Lu X, Chin YE.

(9) Fucoxanthin Attenuates Oxidative Damage by Activating the Sirt1/Nrf2/HO-1 Signaling Pathway to Protect the Kidney from Ischemia-Reperfusion InjuryOxidative medicine and cellular longevityJanuary 1, 2022Mao H, Wang L, Xiong Y, Jiang G, Liu X.

(10) Ginsenoside Rg3 Attenuates TNF-α-Induced Damage in Chondrocytes through Regulating SIRT1-Mediated Anti-Apoptotic and Anti-Inflammatory MechanismsAntioxidants (Basel, Switzerland)December 10, 2021Ma CH, Chou WC, Wu CH, Jou IM, Tu YK, Hsieh PL, Tsai KL.

(11) Patchouli alcohol ameliorates skeletal muscle insulin resistance and NAFLD via AMPK/SIRT1-mediated suppression of inflammationMolecular and cellular endocrinologyDecember 1, 2021Pyun DH, Kim TJ, Park SY, Lee HJ, Abd El-Aty AM, Jeong JH, Jung TW.

(12) Oxymatrine attenuates oxidized low‑density lipoprotein‑induced HUVEC injury by inhibiting NLRP3 inflammasome‑mediated pyroptosis via the activation of the SIRT1/Nrf2 signaling pathwayInternational journal of molecular medicineOctober 1, 2021Jin X, Fu W, Zhou J, Shuai N, Yang Y, Wang B.

(13) MicroRNA-217 modulates inflammation, oxidative stress, and lung injury in septic mice via SIRT1Free radical researchJanuary 1, 2021Yan J, Yang F, Wang D, Lu Y, Liu L, Wang Z.

(14) Synthetic modified Fezf2 mRNA (modRNA) with concurrent small molecule SIRT1 inhibition enhances refinement of cortical subcerebral/corticospinal neuron identity from mouse embryonic stem cellsPloS oneJanuary 1, 2021Sadegh C, Ebina W, Arvanites AC, Davidow LS, Rubin LL, Macklis JD.

(15) NAD(+)-boosting therapy alleviates nonalcoholic fatty liver disease via stimulating a novel exerkine Fndc5/irisinTheranosticsJanuary 1, 2021Li DJ, Sun SJ, Fu JT, Ouyang SX, Zhao QJ, Su L, Ji QX, Sun DY, Zhu JH, Zhang GY, et al.

(16) Polysulfide-mediated sulfhydration of SIRT1 prevents diabetic nephropathy by suppressing phosphorylation and acetylation of p65 NF-κB and STAT3Redox biologyJanuary 1, 2021Sun HJ, Xiong SP, Cao X, Cao L, Zhu MY, Wu ZY, Bian JS.

(17) Acacetin exerts antioxidant potential against atherosclerosis through Nrf2 pathway in apoE(-/-) MiceJournal of cellular and molecular medicineJanuary 1, 2021Wu Y, Song F, Li Y, Li J, Cui Y, Hong Y, Han W, Wu W, Lakhani I, Li G, et al.

(18) SIRT1 promotes pulmonary artery endothelial cell proliferation by targeting the Akt signaling pathwayExperimental and therapeutic medicineDecember 1, 2020Xi L, Ruan L, Yao X, Zhang D, Yuan H, Li Q, Yan C.

(19) The protective effect of doxofylline against lipopolysaccharides (LPS)-induced activation of NLRP3 inflammasome is mediated by SIRT1 in human pulmonary bronchial epithelial cellsArtificial cells, nanomedicine, and biotechnologyDecember 1, 2020Jiao P, Li W, Shen L, Li Y, Yu L, Liu Z.

(20) Mechanism underlying the significant role of the miR-4262/SIRT1 axis in children with inflammatory bowel diseaseExperimental and therapeutic medicineSeptember 1, 2020Deng X, Shang L, Du M, Yuan L, Xiong L, Xie X.

Be the First to Write a Review!